These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1901425)

  • 21. US looking for short cuts to speed drug approval.
    Ezzell C
    Nature; 1988 Aug; 334(6183):553. PubMed ID: 3043232
    [No Abstract]   [Full Text] [Related]  

  • 22. Linking choice with AIDS.
    Campbell CS
    Hastings Cent Rep; 1990; 20(4):4. PubMed ID: 2211086
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
    AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
    Cohen J;
    AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green light for ddI.
    Gershon D
    Nature; 1991 Oct; 353(6345):589. PubMed ID: 1922374
    [No Abstract]   [Full Text] [Related]  

  • 26. New medicines in development for AIDS: 1994 survey from the Pharmaceutical Research and Manufacturers of America.
    Pediatr AIDS HIV Infect; 1995 Apr; 6(2):101-10. PubMed ID: 11361382
    [No Abstract]   [Full Text] [Related]  

  • 27. Committee recommends approval of AIDS drug.
    Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052209
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS treatment: 'parallel trick' for ddI.
    McGourty C
    Nature; 1989 Oct; 341(6242):474. PubMed ID: 2507927
    [No Abstract]   [Full Text] [Related]  

  • 30. "Compassionate" release of DDI.
    Lancet; 1989 Nov; 2(8671):1079-80. PubMed ID: 2572804
    [No Abstract]   [Full Text] [Related]  

  • 31. Approval of ddC for AIDS patients.
    Am Fam Physician; 1992 Aug; 46(2):589. PubMed ID: 1636570
    [No Abstract]   [Full Text] [Related]  

  • 32. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
    Lovell MC
    Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA Advisory Committee stalemates on delavirdine.
    AIDS Patient Care STDS; 1997 Apr; 11(2):96-7. PubMed ID: 11361773
    [No Abstract]   [Full Text] [Related]  

  • 34. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental AIDS drug d4T, now available to patients in critical need.
    Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862
    [No Abstract]   [Full Text] [Related]  

  • 36. Activists now urge caution on approval of new AIDS drug.
    MacIlwain C
    Nature; 1993 Sep; 365(6445):378. PubMed ID: 8413575
    [No Abstract]   [Full Text] [Related]  

  • 37. AIDS researchers seek criteria for vaccines.
    Check E
    Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS drugs in development. Facts and comparisons.
    Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
    [No Abstract]   [Full Text] [Related]  

  • 39. Symptom-reduction trials at FDA clinical trials workshop. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Sep; (no 231):7. PubMed ID: 11362873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer and AIDS groups push for changes in drug approval process.
    Anderson LF
    J Natl Cancer Inst; 1989 Jun; 81(11):829-31. PubMed ID: 2724348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.